Refine by
Diseased Joint Articles & Analysis
24 news found
Dedicated to the research of new immunotherapeutic vaccines in oncology and prophylactic vaccines for contagious diseases, the aim of the joint Institut Pasteur – Oncovita laboratory is to design and develop vaccine candidates through to proof of concept in humans. ...
ByOncoVITA
The company is also co-developing new drugs with Mayo Clinic in key disease areas, including oncology, hematology, bone/joint disorders, and neurological diseases. ...
The CUVIS-Joint robotic platform is currently being used by surgeons in Korea and India with great success. ...
The core technology of the TSolution One has been used in thousands of successful total joint replacements worldwide. THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent ...
End of study brings Robocath closer to commercializing R-One in China in 2023 149 patients enrolled over six months in four Chinese centers Results of first vascular robotics study on this scale in China will be published in March 2023 Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, ...
ByRobocath
The core technology of the TSolution One has been used in thousands of successful total joint replacements worldwide. THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent ...
VeriSIM will engage Mayo Clinic physician researchers in key disease areas including oncology, hematology, bone/joint-disorders, and neurological diseases. ...
Glucosamine is a natural sugar found in the fluid around joints, animal bones, bone marrow, shellfish and fungi. The glucosamine in supplements usually comes from shellfish, but there are also synthetic forms.Does Glucosamine Cause Liver ...
.*, of INOV8 Surgical, a leading ambulatory surgical center (ASC) in Houston specializing in outpatient total joint procedures, is approaching a key milestone with THINK’s active robot technology. ...
Dry Eye Syndrome is a chronic disease that affects the productivity and quality of life of 1.52 billion people worldwide [1]. The COVID-19 pandemic has further exacerbated the problem, as prolonged time in front of screens is a risk factor for the disease. Other risk factors include aging, eye surgeries, dry environments, long-term wearing of contact lenses, ...
The core technology of the TSolution One has been used in thousands of successful total joint replacements worldwide. THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent ...
“Given his track record of success over decades with Stryker Corporation, including his time as president of the Joint Replacement Division and his experience with Mako robotic-arm technology, Stuart Simpson is uniquely qualified to lead THINK. ...
” About Hyalex Orthopaedics Hyalex is a privately-held medical device company headquartered in Lexington, MA, developing transformational synthetic cartilage technology and implant systems for diseased and damaged joints. HYALEX® Cartilage is protected by more than 17 patents and trademarks worldwide. ...
“A reliable and reproducible solution for articular joint pain caused by cartilage lesions is one of the largest untapped opportunities in orthopaedics,” said Mr. ...
Scientists have found that the dysbiosis of gut microbiota is linked to malnutrition, obesity, diabetes, and various other diseases. Researchers who worked on a joint project among Columbia University Medical Center, Albert Einstein College of Medicine, and St John's University sought to elucidate the mechanisms by which maternal consumption of a high-fat diet ...
In sports alone, knee injuries account for 41% of all injuries, and rapidly increasing in prevalence is knee osteoarthritis, a disabling joint disease. The KneeKGTM goes beyond the current standard of care by providing clinicians with real-time, quantifiable data that objectively and accurately assess dynamic knee function to prevent or rehab knee pain and ...
ByEmovi
LISCure signed a Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic for liver disease programs this year, and a joint research program is currently in progress. ...
Innovation Center project of Merck collaborates to develop smart neuro-modulation for targeted treatment of chronic diseases. Joint development agreement represents a promising step towards a highly selective and efficient next generation of bioelectronic therapies powered by graphene. ...
” “The HYALEX Cartilage System is exciting because its biomimetic material properties create the potential to replace a damaged joint surface, and thereby interrupt the progression of cartilage degeneration,” said Dr. ...
About Osteoarthritis Osteoarthritis is the most common chronic degenerative joint disease, characterized by progressive wear of joint cartilage. Clinical manifestations of OA in the knee include, but are not limited to, pain in and around the joint and limited joint motion. Due to the inability of ...